OcuCure Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ocucure.com
A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR
Phase 2
Terminated
- Conditions
- Proliferative Diabetic Retinopathy (PDR)
- Interventions
- Drug: Placebo ComparatorDrug: 2% OC-10X
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- OcuCure Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02735369
- Locations
- 🇧🇩
Bangladesh Eye Hospital, Dhaka, Bangladesh
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- OcuCure Therapeutics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01869933
- Locations
- 🇧🇩
Bangladesh Eye Hospital, Dhaka, Bangladesh
© Copyright 2025. All Rights Reserved by MedPath